ES2070103T3 - Derivados de ciclobutenodionatriptaminas contra la migraña. - Google Patents

Derivados de ciclobutenodionatriptaminas contra la migraña.

Info

Publication number
ES2070103T3
ES2070103T3 ES94402059T ES94402059T ES2070103T3 ES 2070103 T3 ES2070103 T3 ES 2070103T3 ES 94402059 T ES94402059 T ES 94402059T ES 94402059 T ES94402059 T ES 94402059T ES 2070103 T3 ES2070103 T3 ES 2070103T3
Authority
ES
Spain
Prior art keywords
derivatives
cyclobutenodionatriptaminas
against migraine
migraine
cyclobutenodiona
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94402059T
Other languages
English (en)
Other versions
ES2070103T1 (es
Inventor
Jonas A Gylys
Edward H Ruediger
David W Smith
Carola Solomon
Joseph P Yevich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ES2070103T1 publication Critical patent/ES2070103T1/es
Application granted granted Critical
Publication of ES2070103T3 publication Critical patent/ES2070103T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)

Abstract

SE PROPONE UNA SERIE DE NUEVOS DERIVADOS DE TRIPTAMINA SUSTITUIDA CON CICLOBUTENODIONA DE FORMULA I PARA USO EN EL ALIVIO DE JAQUECAS VASCULARES.
ES94402059T 1993-09-16 1994-09-14 Derivados de ciclobutenodionatriptaminas contra la migraña. Expired - Lifetime ES2070103T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/122,112 US5382592A (en) 1993-09-16 1993-09-16 Antimigraine cyclobutenedione derivatives of tryptamines

Publications (2)

Publication Number Publication Date
ES2070103T1 ES2070103T1 (es) 1995-06-01
ES2070103T3 true ES2070103T3 (es) 1998-11-01

Family

ID=22400690

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94402059T Expired - Lifetime ES2070103T3 (es) 1993-09-16 1994-09-14 Derivados de ciclobutenodionatriptaminas contra la migraña.

Country Status (10)

Country Link
US (1) US5382592A (es)
EP (1) EP0644187B1 (es)
JP (1) JPH07179344A (es)
AT (1) ATE167853T1 (es)
AU (1) AU671925B2 (es)
CA (1) CA2130519A1 (es)
DE (2) DE644187T1 (es)
DK (1) DK0644187T3 (es)
ES (1) ES2070103T3 (es)
GR (1) GR950300041T1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US6066092A (en) * 1997-11-06 2000-05-23 Cady; Roger K. Preemptive prophylaxis of migraine device and method
CN1729174B (zh) * 2002-12-20 2015-10-21 西巴特殊化学品控股有限公司 胺的合成以及用于合成胺的中间体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79215B (es) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8924373D0 (en) * 1989-10-30 1989-12-20 Beecham Group Plc Novel compounds
GB9104136D0 (en) * 1991-02-27 1991-04-17 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
DE69411339D1 (de) 1998-08-06
DE69411339T2 (de) 1999-04-08
EP0644187B1 (en) 1998-07-01
ATE167853T1 (de) 1998-07-15
US5382592A (en) 1995-01-17
DK0644187T3 (da) 1999-04-12
JPH07179344A (ja) 1995-07-18
CA2130519A1 (en) 1995-03-17
DE644187T1 (de) 1995-10-12
GR950300041T1 (en) 1995-07-31
AU671925B2 (en) 1996-09-12
ES2070103T1 (es) 1995-06-01
AU7297494A (en) 1995-03-30
EP0644187A1 (en) 1995-03-22

Similar Documents

Publication Publication Date Title
YU47204B (sh) Derivati didehidro-vitamina d3
ES2159560T3 (es) Inhibicion del crecimiento del pelo.
AR004348A1 (es) Reduccion del crecimiento del cabello
ES2119762T3 (es) Tratamiento de la catarata con la ayuda de derivados 15-ceto-prostaglandinas.
ES2157958T3 (es) Uso de venlafaxina o de un compuesto de ariloxipropanamina para la preparacion de un medicamento para el tratamiento de la incontinencia urinaria.
PT1193270E (pt) Pirrolobenzodiazepinas
AR038434A2 (es) Compuesto 14,15-dihidro-16-oxoparahercuamida y compuestos 2-desoxo de parahercuamida y marcfortina
AU9309898A (en) Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa
ES2175084T3 (es) Uso de supresores de angiogenesis para inhibir el crecimiento del pelo.
ES2135347B1 (es) Hidroxifeniltriazinas.
ES2052495T3 (es) Terapia de fluidos con aniones l-lactato y/o piruvato.
ES2031822T3 (es) Un procedimiento para preparar una composicion farmaceutica con propiedades inhibidoras de la renina.
ATE233274T1 (de) Oxyiminopregnancarbolactone
AR020970A1 (es) Metodo de reduccion del crecimiento del pelo en mamiferos
SV1994000083A (es) Derivados de indol, su preparacion y uso, ref. 1215ml/sv.
ES2138247T3 (es) Composicion y uso.
ES2063097T3 (es) Inhibidor de la glicosidasa salbostatina, procedimiento para su preparacion y su empleo.
ES2057069T3 (es) Conjugado de prostaglandina y polisacarido.
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
ES2056153T3 (es) Expectorante que comprende un derivado hidroxialquilcisteina.
ES2070103T3 (es) Derivados de ciclobutenodionatriptaminas contra la migraña.
ES2155442T3 (es) Un derivado de oxazolina, su produccion y su uso.
ES2174113T3 (es) Nuevos derivados de ((3-alcoxi-fenoxi)-etil)-dialquilamina y su utilizacion como anestesicos locales.
DK0734380T3 (da) 4-Benzoylisoxazoler samt deres anvendelse som herbicider
AR013411A1 (es) Composicion de aplicacion para tratamientos antivirales y afecciones micosicas y/o bacterianas y utilizacion de dichas composiciones.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 644187

Country of ref document: ES